Latest Insider Transactions at Resmed Inc (RSMDF)
This section provides a real-time view of insider transactions for Resmed Inc (RSMDF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RESMED INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RESMED INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 08
2024
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,683
+3.12%
|
$1,233,372
$84.98 P/Share
|
Jul 08
2024
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.1%
|
$194,000
$194.35 P/Share
|
Jun 10
2024
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.09%
|
$209,000
$209.81 P/Share
|
Jun 07
2024
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,683
-3.22%
|
$3,098,113
$211.66 P/Share
|
Jun 07
2024
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,683
+3.12%
|
$1,233,372
$84.98 P/Share
|
Jun 04
2024
|
Michael J Rider Global General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-3.98%
|
$55,002
$206.33 P/Share
|
May 24
2024
|
Carol Burt Director |
SELL
Bona fide gift
|
Indirect |
47
-0.31%
|
-
|
May 15
2024
|
Jan De Witte Director |
SELL
Open market or private sale
|
Direct |
360
-4.57%
|
$78,480
$218.29 P/Share
|
May 15
2024
|
Peter C Farrell Director |
SELL
Bona fide gift
|
Direct |
68,200
-43.33%
|
-
|
May 08
2024
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,000
-12.37%
|
$2,743,000
$211.37 P/Share
|
May 08
2024
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+10.25%
|
$1,212,000
$101.64 P/Share
|
May 07
2024
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,683
-3.22%
|
$3,171,528
$216.5 P/Share
|
May 07
2024
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,683
+1.57%
|
$1,233,372
$84.98 P/Share
|
Apr 29
2024
|
Carol Burt Director |
SELL
Bona fide gift
|
Indirect |
234
-1.54%
|
-
|
Apr 29
2024
|
Karen Drexler Director |
SELL
Open market or private sale
|
Direct |
425
-4.79%
|
$90,950
$214.92 P/Share
|
Mar 04
2024
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
81
-1.21%
|
$14,580
$180.0 P/Share
|
Mar 01
2024
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
200
-2.9%
|
$34,600
$173.25 P/Share
|
Feb 22
2024
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
10,935
-6.5%
|
$1,990,170
$182.66 P/Share
|
Nov 27
2023
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.13%
|
$456,000
$152.62 P/Share
|
Nov 22
2023
|
Michael J Rider Global General Counsel |
SELL
Bona fide gift
|
Direct |
72
-1.03%
|
-
|
Nov 20
2023
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,375
-9.03%
|
$203,500
$148.94 P/Share
|
Nov 20
2023
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-2.76%
|
$54,168
$148.94 P/Share
|
Nov 20
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,352
-0.53%
|
$348,096
$148.94 P/Share
|
Nov 16
2023
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+18.33%
|
-
|
Nov 16
2023
|
Richard Sulpizio Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+9.57%
|
-
|
Nov 16
2023
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+16.49%
|
-
|
Nov 16
2023
|
John Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
884
+22.98%
|
-
|
Nov 16
2023
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+31.49%
|
-
|
Nov 16
2023
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+0.97%
|
-
|
Nov 16
2023
|
Desney Tan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+31.49%
|
-
|
Nov 16
2023
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+7.25%
|
-
|
Nov 16
2023
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
884
+9.06%
|
-
|
Nov 15
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,678
-1.27%
|
$863,056
$152.04 P/Share
|
Nov 15
2023
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,678
+1.26%
|
$323,646
$57.76 P/Share
|
Nov 13
2023
|
Michael J Rider Global General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
437
-1.51%
|
$62,491
$143.6 P/Share
|
Nov 13
2023
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-3.65%
|
$146,575
$143.6 P/Share
|
Nov 13
2023
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,703
-5.16%
|
$243,529
$143.6 P/Share
|
Nov 13
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,450
-0.63%
|
$1,208,350
$143.6 P/Share
|
Nov 13
2023
|
Lucile Blaise President, Sleep & RC Business |
SELL
Payment of exercise price or tax liability
|
Direct |
135
-1.29%
|
$19,305
$143.6 P/Share
|
Nov 13
2023
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-0.18%
|
$46,475
$143.6 P/Share
|
Nov 13
2023
|
Harjit Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
79
-1.09%
|
$11,297
$143.6 P/Share
|
Nov 01
2023
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
25
-0.34%
|
$3,575
$143.42 P/Share
|
Oct 16
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.25%
|
$794,500
$140.7 P/Share
|
Oct 16
2023
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.23%
|
$323,475
$57.76 P/Share
|
Oct 02
2023
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
25
-0.34%
|
$3,625
$145.92 P/Share
|
Sep 15
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.25%
|
$828,550
$146.35 P/Share
|
Sep 15
2023
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.23%
|
$323,475
$57.76 P/Share
|
Sep 01
2023
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
25
-0.34%
|
$4,025
$161.15 P/Share
|
Aug 25
2023
|
Lucile Blaise President, Sleep & RC Business |
SELL
Payment of exercise price or tax liability
|
Direct |
379
-3.53%
|
$62,535
$165.67 P/Share
|
Aug 17
2023
|
Michael J Rider Global General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,247
+23.21%
|
-
|